Valuation: Perrigo Company plc

Market Cap 198.02Cr 593.81Cr 169.71Cr 158.76Cr 145.15Cr 273.9Cr 19TCr 276.82Cr 1.88TCr 730.49Cr 9.52TCr 743.52Cr 727.42Cr 32TCr P/E 2026 *
1,427x
P/E 2027 * 11.9x
Enterprise Value 488.48Cr 1.46TCr 418.63Cr 391.63Cr 358.05Cr 675.67Cr 47TCr 682.85Cr 4.63TCr 1.8TCr 23TCr 1.83TCr 1.79TCr 78TCr EV / Sales 2026 *
1.2x
EV / Sales 2027 * 1.16x
Free-Float
99.6%
Yield 2026 *
8.11%
Yield 2027 * 8.32%
Manager TitleAgeSince
Chief Executive Officer 63 07/06/2026
Director of Finance/CFO 51 16/05/2022
Chief Operating Officer - 23/06/2025
Director TitleAgeSince
Director/Board Member 75 01/11/2014
Director/Board Member 61 07/11/2016
Director/Board Member 70 06/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
+0.34%-2.55% - - 197.75Cr
-0.67%+5.39%+75.21%+127.54% 1,11900Cr
+1.04%+4.07%+52.29%+65.39% 65TCr
-0.17%+5.67%+25.60%+80.40% 47TCr
-1.38%+4.02%+41.64%+42.38% 37TCr
-0.52%+2.72%+24.32%+41.06% 30TCr
-1.06%+4.76%+1.19%+12.65% 26TCr
+1.03%+5.83%+51.11%+72.96% 24TCr
-0.53%+2.34%-17.77%-53.66% 21TCr
+0.42%+5.63%+27.86%+92.24% 18TCr
Average -0.15%+4.81%+31.27%+53.44% 42.22TCr
Weighted average by Cap. -0.23%+4.95%+43.93%+72.99%

Financials

2026 *2027 *
Net sales 405.95Cr 1.22TCr 347.9Cr 325.46Cr 297.55Cr 561.5Cr 39TCr 567.47Cr 3.85TCr 1.5TCr 20TCr 1.52TCr 1.49TCr 65TCr 408.93Cr 1.23TCr 350.45Cr 327.85Cr 299.74Cr 565.63Cr 39TCr 571.64Cr 3.88TCr 1.51TCr 20TCr 1.54TCr 1.5TCr 65TCr
Net income -22Cr -67Cr -19Cr -18Cr -16Cr -31Cr -2.15TCr -31Cr -212.6Cr -83Cr -1.08TCr -84Cr -82Cr -3.57TCr -5.7Cr -17Cr -4.88Cr -4.57Cr -4.17Cr -7.88Cr -545.31Cr -7.96Cr -54Cr -21Cr -273.82Cr -21Cr -21Cr -905.98Cr
Net Debt 290.46Cr 871Cr 248.92Cr 232.87Cr 212.9Cr 401.76Cr 28TCr 406.04Cr 2.76TCr 1.07TCr 14TCr 1.09TCr 1.07TCr 46TCr 278.37Cr 834.76Cr 238.57Cr 223.18Cr 204.04Cr 385.04Cr 27TCr 389.14Cr 2.64TCr 1.03TCr 13TCr 1.05TCr 1.02TCr 44TCr
Logo Perrigo Company plc
Perrigo Company plc is a pure-play self-care company. The Company provides health and wellness solutions. Its segments include Self Care, Specialty Care, and Infant Formula. Self Care comprises Upper Respiratory, Digestive Health, Pain & Sleep and Healthy Lifestyle product categories globally. Specialty Care comprises our Women's Health and Skin Health product categories globally. Infant Formula comprises the Infant Formula product category, which includes nutritional products designed to meet the dietary needs of infants. It provides a store-branded private label provider of self-care products in many categories, including upper respiratory, healthy lifestyle and women's health, along with brands including Opill and Mederma. Its Europe portfolio consists primarily of brands, including Compeed, ellaOne, Solpadeine, Jungle Formula, and ACO. Its upper respiratory products include Nasonex 24HR Energy, Mucus DM, All Day Allergy, Nighttime Cold & Flu, and Allergy Relief.
Employees
8,100
Trader
Investor
Global
Quality
ESG MSCI
BB